Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Anti-Cancer Drugs
|
October 10, 2020
Dabrafenib and trametinib induced pancreatitis: a case report and review of the literature
Francesca R Ogliari, Giovanni L Rodolfo Masera, Rossana Gueli, et al.
Immunotherapy
|
April 24, 2020
Psoriatic arthritis induced by anti-PD1 and treated with apremilast: a case report and review of the literature
Olga Nigro, Graziella Pinotti, Rossana Gueli, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B
|
November 7, 2013
Pyrosequencing for EGFR mutation detection: diagnostic accuracy and clinical implications
Nora Sahnane, Rossana Gueli, Maria G Tibiletti, et al.
Melanoma Research
|
May 20, 2024
Cytomegalovirus gastritis as a rare adverse event during combined ipilimumab and nivolumab in a patient with melanoma
Alice Indini, Rossana Gueli, Michele Cerati, et al.
Anti-Cancer Drugs
|
February 4, 2020
Cyclin-dependent kinase inhibitors plus aromatase inhibitor in first-line treatment hormone-receptor-positive/HER2-negative advanced breast cancer women with or without visceral disease: time to turn page?
Olga Nigro, Cristina Marrazzo, Elisa Gallerani, et al.
Cancers
|
July 13, 2024
Neoadjuvant Chemotherapy in Breast Cancer: Evaluation of the Impact on Surgical Outcomes and Prognosis
Corrado Chiappa, Maltecca Greta, Leoni Miriam, et al.
International Journal of Surgery (London, England)
|
January 2, 2014
Neuroendocrine breast cancer: retrospective analysis of 96 patients and review of literature
Francesca Rovera, Matteo Lavazza, Stefano La Rosa, et al.
Breast Cancer Research and Treatment
|
August 28, 2021
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9)
Rosalba Torrisi, Raffaella Palumbo, Rita De Sanctis, et al.
Cancers
|
June 2, 2021
A Retrospective Analysis of Dabrafenib and/or Dabrafenib Plus Trametinib Combination in Patients with Metastatic Melanoma to Characterize Patients with Long-Term Benefit in the Individual Patient Program (DESCRIBE III)
Victoria G Atkinson, Pietro Quaglino, Massimo Aglietta, et al.
The Oncologist
|
October 16, 2016
Eribulin in Male Patients With Breast Cancer: The First Report of Clinical Outcomes
Francesco Giotta, Luigi Acito, Giampiero Candeloro, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Anti-Cancer Drugs
|
October 10, 2020
Dabrafenib and trametinib induced pancreatitis: a case report and review of the literature
Francesca R Ogliari, Giovanni L Rodolfo Masera, Rossana Gueli, et al.
Immunotherapy
|
April 24, 2020
Psoriatic arthritis induced by anti-PD1 and treated with apremilast: a case report and review of the literature
Olga Nigro, Graziella Pinotti, Rossana Gueli, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B
|
November 7, 2013
Pyrosequencing for EGFR mutation detection: diagnostic accuracy and clinical implications
Nora Sahnane, Rossana Gueli, Maria G Tibiletti, et al.
Melanoma Research
|
May 20, 2024
Cytomegalovirus gastritis as a rare adverse event during combined ipilimumab and nivolumab in a patient with melanoma
Alice Indini, Rossana Gueli, Michele Cerati, et al.
Anti-Cancer Drugs
|
February 4, 2020
Cyclin-dependent kinase inhibitors plus aromatase inhibitor in first-line treatment hormone-receptor-positive/HER2-negative advanced breast cancer women with or without visceral disease: time to turn page?
Olga Nigro, Cristina Marrazzo, Elisa Gallerani, et al.
Cancers
|
July 13, 2024
Neoadjuvant Chemotherapy in Breast Cancer: Evaluation of the Impact on Surgical Outcomes and Prognosis
Corrado Chiappa, Maltecca Greta, Leoni Miriam, et al.
International Journal of Surgery (London, England)
|
January 2, 2014
Neuroendocrine breast cancer: retrospective analysis of 96 patients and review of literature
Francesca Rovera, Matteo Lavazza, Stefano La Rosa, et al.
Breast Cancer Research and Treatment
|
August 28, 2021
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9)
Rosalba Torrisi, Raffaella Palumbo, Rita De Sanctis, et al.
Cancers
|
June 2, 2021
A Retrospective Analysis of Dabrafenib and/or Dabrafenib Plus Trametinib Combination in Patients with Metastatic Melanoma to Characterize Patients with Long-Term Benefit in the Individual Patient Program (DESCRIBE III)
Victoria G Atkinson, Pietro Quaglino, Massimo Aglietta, et al.
The Oncologist
|
October 16, 2016
Eribulin in Male Patients With Breast Cancer: The First Report of Clinical Outcomes
Francesco Giotta, Luigi Acito, Giampiero Candeloro, et al.
Page
of 2